MorphoSys (NASDAQ:MOR) Rating Reiterated by Leerink Partnrs

MorphoSys (NASDAQ:MOR) Rating Reiterated by Leerink Partnrs

MorphoSys (NASDAQ:MOR – Get Free Report)‘s stock had its “market perform” rating reissued by analysts at Leerink Partnrs in a research note issued to investors on Wednesday, PriceTargets.com reports. Leerink Partnrs also issued estimates for MorphoSys’ FY2026 earnings at ($0.78) EPS. A number of other equities research analysts have also weighed in on the stock. […]

Related Keywords

United States , Leerink Partnrs , Morgan Stanley , Envestnet Asset Management Inc , Qube Research Technologies Ltd , Virtu Financial , Goldman Sachs Group , Morphosys Company Profile , Jpmorgan Chase Co , Get Free Report , Technologies Ltd , Envestnet Asset Management , Morphosys Daily , Morphosys , Nasdaq Mor , Humor , Medical , Reiterated Rating ,

© 2025 Vimarsana